HK1119063A1 - Orally disintegrating powder comprising cilostazol and mannitol - Google Patents

Orally disintegrating powder comprising cilostazol and mannitol

Info

Publication number
HK1119063A1
HK1119063A1 HK08110964.3A HK08110964A HK1119063A1 HK 1119063 A1 HK1119063 A1 HK 1119063A1 HK 08110964 A HK08110964 A HK 08110964A HK 1119063 A1 HK1119063 A1 HK 1119063A1
Authority
HK
Hong Kong
Prior art keywords
cilostazol
mannitol
orally disintegrating
disintegrating powder
powder
Prior art date
Application number
HK08110964.3A
Other languages
English (en)
Inventor
Masafumi Toda
Tadashi Mukai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1119063A1 publication Critical patent/HK1119063A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK08110964.3A 2005-06-29 2008-09-30 Orally disintegrating powder comprising cilostazol and mannitol HK1119063A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005190156 2005-06-29
PCT/JP2006/313345 WO2007001086A1 (en) 2005-06-29 2006-06-28 Orally disintegrating powder comprising cilostazol and mannitol

Publications (1)

Publication Number Publication Date
HK1119063A1 true HK1119063A1 (en) 2009-02-27

Family

ID=37120411

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110964.3A HK1119063A1 (en) 2005-06-29 2008-09-30 Orally disintegrating powder comprising cilostazol and mannitol

Country Status (19)

Country Link
US (1) US20090110737A1 (zh)
EP (1) EP1901717B1 (zh)
JP (1) JP4131747B2 (zh)
KR (1) KR101302293B1 (zh)
CN (1) CN101212955B (zh)
AR (1) AR057413A1 (zh)
AU (1) AU2006263068B2 (zh)
CA (1) CA2608629C (zh)
CY (1) CY1113164T1 (zh)
DK (1) DK1901717T3 (zh)
ES (1) ES2388613T3 (zh)
HK (1) HK1119063A1 (zh)
MY (1) MY147888A (zh)
PL (1) PL1901717T3 (zh)
PT (1) PT1901717E (zh)
RU (1) RU2426529C2 (zh)
SI (1) SI1901717T1 (zh)
TW (1) TWI383809B (zh)
WO (1) WO2007001086A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3207921A1 (en) 2007-09-14 2017-08-23 Wockhardt Limited Rhein or diacerein compositions
WO2009107864A2 (en) * 2008-02-29 2009-09-03 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet
US20150141517A1 (en) 2013-11-15 2015-05-21 Shin-Etsu Chemical Co., Ltd. Granulated composite, rapid release tablet and method for producing same
KR101748215B1 (ko) * 2015-05-29 2017-06-20 한국유나이티드제약 주식회사 경구용 서방성 제제
RU2694233C2 (ru) * 2017-10-13 2019-07-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Средство, обладающее ноотропным воздействием на организм

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029878A (en) * 1975-05-19 1977-06-14 Ici United States Inc. Process for preparing mannitol from glucose
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
AU3221401A (en) * 1999-11-30 2001-06-12 Rajesh Jain Fast dissolving composition with prolonged sweet taste
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
WO2005055989A1 (ja) * 2003-12-09 2005-06-23 Dainippon Sumitomo Pharma Co., Ltd. 薬物含有粒子および該粒子を含む固形製剤
JP2008536922A (ja) * 2005-04-22 2008-09-11 テバ・ファーマシューティカルズ・ユーエスエー・インコーポレイテッド オランザピンの医薬用経口崩壊錠

Also Published As

Publication number Publication date
JP4131747B2 (ja) 2008-08-13
PL1901717T3 (pl) 2012-12-31
CA2608629A1 (en) 2007-01-04
JP2008528442A (ja) 2008-07-31
PT1901717E (pt) 2012-08-07
CA2608629C (en) 2013-11-19
WO2007001086A1 (en) 2007-01-04
TW200740469A (en) 2007-11-01
CN101212955B (zh) 2012-07-18
CN101212955A (zh) 2008-07-02
AU2006263068A1 (en) 2007-01-04
EP1901717B1 (en) 2012-07-18
US20090110737A1 (en) 2009-04-30
RU2426529C2 (ru) 2011-08-20
KR20080021158A (ko) 2008-03-06
AR057413A1 (es) 2007-12-05
EP1901717A1 (en) 2008-03-26
TWI383809B (zh) 2013-02-01
AU2006263068B2 (en) 2011-08-18
RU2008103213A (ru) 2009-08-10
CY1113164T1 (el) 2016-04-13
MY147888A (en) 2013-01-31
DK1901717T3 (da) 2012-08-20
ES2388613T3 (es) 2012-10-16
SI1901717T1 (sl) 2012-10-30
KR101302293B1 (ko) 2013-09-03

Similar Documents

Publication Publication Date Title
EP1887067A4 (en) FLUORESCENT AND ITS USE
EP1889195A4 (en) PRODUCTION-DESIGN DESIGN AND DESIGNED PRODUCTION
PL385229A1 (pl) Sposoby i związki pośrednie
GB0512940D0 (en) Compounds and their use
EP1787978A4 (en) DIIMMONIUM COMPOUND AND USE THEREOF
EP1895838A4 (en) COMPOSITIONS AND METHODS
EP1809434A4 (en) STRAINER BIT RIGIDIFIED WITH TORSION
IL191072A0 (en) Therapeutic compositions and methods
GB0707077D0 (en) End mill
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
GB0520743D0 (en) Compounds and their use
GB0516069D0 (en) Pharmaceutical and use thereof
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
HK1119063A1 (en) Orally disintegrating powder comprising cilostazol and mannitol
IL186337A0 (en) Stannsoporfin compositions and administration
IL185223A0 (en) Compounds and uses thereof
GB0501348D0 (en) Compositions and methods
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
GB0520935D0 (en) Integrated processor-template-system and project
GB0502843D0 (en) Jig-was and jig-will
AU157610S (en) Pepper mill
ZA200804378B (en) Iminopropene compound and use thereof
GB0517240D0 (en) Chronorotron mk1-system and project

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160628